Muhammad Shaheen , L. Daniel Wurtz , Eric G. Brocken , Laura M. Warmke
{"title":"EWSR1::骨内nfatc2重排肉瘤病例报告及文献复习","authors":"Muhammad Shaheen , L. Daniel Wurtz , Eric G. Brocken , Laura M. Warmke","doi":"10.1016/j.hpr.2022.300680","DOIUrl":null,"url":null,"abstract":"<div><p>Round cell sarcomas with <em>EWSR1</em>-non-ETS fusions are rare and entirely distinct from Ewing sarcoma with canonical fusion. Of these, <em>EWSR1</em>::<em>NFATC2</em>-rearranged sarcoma (ENS) has emerged as a distinct entity. Whereas few cases of ENS have been reported, clinical data regarding biologic behavior remain limited. In order to further characterize this rare sarcoma, we herein report a case of ENS arising in the tibia of a 21-year-old male, who initially presented with a several-year history of lower leg pain. Imaging showed a large, expansile and marrow-replacing lesion with focal cortical breakthrough. Biopsy showed monomorphic epithelioid and spindle cells with clear cell change, mimicking several entities including a myoepithelial tumor and perivascular epithelioid cell tumor (PEComa). Fluorescence in situ hybridization (FISH) was positive for <em>EWSR1</em> gene rearrangement with selective amplification of the 5′ probe, and next-generation sequencing confirmed the presence of a <em>EWSR1</em>::<em>NFATC2</em> translocation. The patient underwent radical resection of the tibial mass and showed no evidence of local recurrence or metastatic disease at 8 months post resection. Given the fully malignant potential of this tumor, knowledge of this rare entity is essential to ensure proper management and prevent misdiagnosis.</p></div>","PeriodicalId":100612,"journal":{"name":"Human Pathology Reports","volume":"30 ","pages":"Article 300680"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772736X22000925/pdfft?md5=435edfd71be50d15f529ada0e7a0218e&pid=1-s2.0-S2772736X22000925-main.pdf","citationCount":"1","resultStr":"{\"title\":\"EWSR1::NFATC2-rearranged sarcoma in bone-case report and review of the literature\",\"authors\":\"Muhammad Shaheen , L. Daniel Wurtz , Eric G. Brocken , Laura M. Warmke\",\"doi\":\"10.1016/j.hpr.2022.300680\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Round cell sarcomas with <em>EWSR1</em>-non-ETS fusions are rare and entirely distinct from Ewing sarcoma with canonical fusion. Of these, <em>EWSR1</em>::<em>NFATC2</em>-rearranged sarcoma (ENS) has emerged as a distinct entity. Whereas few cases of ENS have been reported, clinical data regarding biologic behavior remain limited. In order to further characterize this rare sarcoma, we herein report a case of ENS arising in the tibia of a 21-year-old male, who initially presented with a several-year history of lower leg pain. Imaging showed a large, expansile and marrow-replacing lesion with focal cortical breakthrough. Biopsy showed monomorphic epithelioid and spindle cells with clear cell change, mimicking several entities including a myoepithelial tumor and perivascular epithelioid cell tumor (PEComa). Fluorescence in situ hybridization (FISH) was positive for <em>EWSR1</em> gene rearrangement with selective amplification of the 5′ probe, and next-generation sequencing confirmed the presence of a <em>EWSR1</em>::<em>NFATC2</em> translocation. The patient underwent radical resection of the tibial mass and showed no evidence of local recurrence or metastatic disease at 8 months post resection. Given the fully malignant potential of this tumor, knowledge of this rare entity is essential to ensure proper management and prevent misdiagnosis.</p></div>\",\"PeriodicalId\":100612,\"journal\":{\"name\":\"Human Pathology Reports\",\"volume\":\"30 \",\"pages\":\"Article 300680\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772736X22000925/pdfft?md5=435edfd71be50d15f529ada0e7a0218e&pid=1-s2.0-S2772736X22000925-main.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Human Pathology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772736X22000925\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Pathology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772736X22000925","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
EWSR1::NFATC2-rearranged sarcoma in bone-case report and review of the literature
Round cell sarcomas with EWSR1-non-ETS fusions are rare and entirely distinct from Ewing sarcoma with canonical fusion. Of these, EWSR1::NFATC2-rearranged sarcoma (ENS) has emerged as a distinct entity. Whereas few cases of ENS have been reported, clinical data regarding biologic behavior remain limited. In order to further characterize this rare sarcoma, we herein report a case of ENS arising in the tibia of a 21-year-old male, who initially presented with a several-year history of lower leg pain. Imaging showed a large, expansile and marrow-replacing lesion with focal cortical breakthrough. Biopsy showed monomorphic epithelioid and spindle cells with clear cell change, mimicking several entities including a myoepithelial tumor and perivascular epithelioid cell tumor (PEComa). Fluorescence in situ hybridization (FISH) was positive for EWSR1 gene rearrangement with selective amplification of the 5′ probe, and next-generation sequencing confirmed the presence of a EWSR1::NFATC2 translocation. The patient underwent radical resection of the tibial mass and showed no evidence of local recurrence or metastatic disease at 8 months post resection. Given the fully malignant potential of this tumor, knowledge of this rare entity is essential to ensure proper management and prevent misdiagnosis.